NP/PA Connect
News
Media
Around the PracticeBetween The LinesCase-Based Peer PerspectiveClinical Case CollectiveDermViewExpert PerspectivesFellows Face OffFrontline ForumMedical World NewsPatient PerspectivesPodcastsReadout360Recognize and Refer
Conferences
Conference CoverageConference Listing
Events
Case-Based Roundtable
More
Publication
Dermatology Times
CME/CE
Resources
DermIQInteractive ToolsJob BoardPartner PerspectivesPerspectives in DermatologyPollsSponsored ContentSponsored ResourcesSpot Test
Editorial Advisory Board
Partners

Subscribe

  • NP/PA Connect
  • News
  • Media
  • Conferences
  • Events
  • Publication
  • CME/CE
  • Resources
  • Editorial Advisory Board
  • Partners
  • Subscribe
  • Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
    • Non-Melanoma Skin Cancers
  • Vitiligo
  • Wound Care
Advertisement

Sophia Fruechte

Advertisement

Articles by Sophia Fruechte

Considerations to Best Serve Transgender Patients Seeking Aesthetic Care

BySophia Fruechte,Ronda Farah, MD,Zachary Wendland, MD ,Nathalie Ly,James Pathoulas, MD,Klint Peebles, MD
June 22nd 2023

Ronda Farah, MD, and her colleagues reviewed how dermatology providers play an important role in transgender aesthetic care.

Advertisement

Latest Updated Articles

  • Considerations to Best Serve Transgender Patients Seeking Aesthetic Care
    Considerations to Best Serve Transgender Patients Seeking Aesthetic Care

    Published: June 22nd 2023 | Updated:



Advertisement
Advertisement

Trending on Dermatology Times

1

Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis

2

Kyowa Kirin Takes Full Control of Rocatinlimab Program

3

Phase 2 TYK2 Inhibition Shows Promise in AD

4

Dermatology Times January 2026 Recap

5

The Weekly Roundup: January 26-30

  • About
  • Advertise
  • Contact Us
  • Job Board
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy Policy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us